Meet Our Team
Professor Sir Peng Tee Khaw
Director, Moorfields Biomedical Research Centre
Professor of Glaucoma and Ocular Healing at the UCL Institute of Ophthalmology and Consultant Ophthalmic Surgeon at Moorfields Eye Hospital, London UK. He is also Director of Research and Development at Moorfields Eye Hospital; President of the UK Paediatric Glaucoma Society; and an NIHR Senior Investigator since 2009.
Professor Robin Ali
Theme Lead, Gene Therapy
Professor of Human Molecular Genetics at UCL Institute of Ophthalmology. He is Visiting Professor of Ophthalmology at Kellogg Eye Center, University of Michigan and Founder and Chief Scientific Officer of MeiraGTx, a UK incorporated gene therapy company with offices in London and New York.
Professor Andrew Dick
Theme Lead, Inflammation and Immunology
Andrew Dick is Duke-Elder Professor of Ophthalmology and Director of UCL Institute of Ophthalmology. His work involves basic mechanisms of immune responses in blinding disorders including age-related macular degeneration, ocular inflammation (Uveitis) and experimental platforms for therapeutic development, disease stratification and molecular taxonomy of diseases.
Professor David Garway-Heath
Theme Lead, Visual Assessment and Imaging
Consultant Ophthalmic Surgeon at Moorfields Eye Hospital and International Glaucoma Association Professor for Glaucoma and Allied Studies at the UCL Institute of Ophthalmology.
Earlier this year, he was appointed president of the European Glaucoma Society (EGS) where he was previously vice president.
Professor Andrew Webster
Theme Lead, Genomic Medicine and Informatics
Andrew Webster is Chair of Molecular Ophthalmology at University College London and a Consultant Ophthalmologist at Moorfields Eye Hospital. He leads the Genetics Service at Moorfields, the largest specialist service in the country, which delivers genetic counselling, diagnosis and management for those with paediatric, retinal, optic nerve, cataract and ocular maldevelopment inherited conditions. His research team has discovered genetic mechanisms that underlie retinal dystrophies. He leads the Hearing and Sight Domain of the Genomics England Clinical Interpretation Partnership, a British National study to sequence over 100,000 genomes in those with rare disease and cancer. He trained in Ophthalmology and Genetics in Cambridge, Iowa (USA) and London.
Professor James Bainbridge
Theme Lead, Patient and Public Involvement/Education and Clinical Studies Development
NIHR Research Professor and Professor of Retinal Studies at the UCL Institute of Ophthalmology. He has an established programme of translational research, developing new molecular treatments for retinal disorders. He is also a consultant ophthalmologist at Moorfields Eye Hospital where he is the clinical lead for the world's first clinical trial of gene therapy for inherited eye disease and principle investigator for Europes first clinical trial in the use of stem cell derived-retinal pigment epithelium to treat macular degeneration.
Professor Philip Luthert
Theme Lead, Cross-institutional research collaborative themes and training
Public Engagement Manager
© Copyright 2018 NIHR Moorfields Biomedical Research Centre. All rights reserved.